Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 249

Results For "GE"

10041 News Found

Sanofi India partners with NHM MP to expand NCD, rare disease services
News | May 08, 2026

Sanofi India partners with NHM MP to expand NCD, rare disease services

The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units


Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh
Hospitals | May 08, 2026

Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh

The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services


Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
Digitisation | May 07, 2026

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion

Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows


China poised to launch world’s first CAR-T therapy for gastric cancer
Biopharma | May 07, 2026

China poised to launch world’s first CAR-T therapy for gastric cancer

As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies


Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today
Policy | May 07, 2026

Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today

These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring


Safic-Alcan expands in India with majority stake in SA Ingredients
News | May 07, 2026

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint


Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
News | May 07, 2026

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy


Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness
Policy | May 07, 2026

Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness

The 40-second film brings children to the forefront of the narrative


GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative
Hospitals | May 07, 2026

GIMS Greater Noida expands paediatric orthopaedic care under Healthium's CSR initiative

Supported by Plan International, the partnership will help treat over 1,000 children annually


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical